The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation-and estrogen-dependent gene expression in antiestrogen-resistant breast cancer

• CHU I

収録刊行物

• Cancer Res

  Cancer Res 65 18-25, 2005

詳細情報

• CRID: 1573668925177271680
• NII論文ID: 10018167647
• データソース種別:
  • CiNii Articles